Related Experiment Videos
Non-small-cell lung cancer in the elderly
Fausto Meriggi1, Alberto Zaniboni
1Oncology Department, Poliambulanza, Via Bissolati 57, 25124 Brescia, Italy. zanib@numerica.it
Critical Reviews in Oncology/Hematology
|September 20, 2005
Summary
As the global population ages, non-small-cell lung cancer (NSCLC) screening, diagnosis, and therapy strategies must be tailored for elderly patients. Integrating geriatric and oncologic data improves treatment selection for older adults with NSCLC.
Area of Science:
- Geriatric Oncology
- Thoracic Oncology
Background:
- The global population is aging, with a significant increase in elderly individuals diagnosed with non-small-cell lung cancer (NSCLC).
- NSCLC is the most common cancer in Western countries, disproportionately affecting individuals over 70 years old.
- Existing research on NSCLC has historically underrepresented the elderly population, necessitating specialized strategies.
Purpose of the Study:
- To highlight the importance of developing tailored screening, diagnosis, and therapy strategies for elderly patients with NSCLC.
- To emphasize the growing interest and recent positive trial results (ELVIS, SICOG, MILES) in elderly NSCLC research.
- To underscore the benefits of integrating geriatric and oncologic data for optimized treatment decisions in older adults.
Main Methods:
- Review of recent clinical trials focusing on elderly patients with NSCLC.
- Analysis of the integration of geriatric assessments with oncological data.
- Evaluation of treatment stratification based on patient frailty and candidacy for aggressive therapy.
Main Results:
- Recent trials demonstrate positive outcomes, increasing interest in elderly NSCLC research.
- Geriatric and oncologic data integration facilitates better identification of elderly patients suitable for aggressive treatments.
- This approach helps distinguish between elderly patients who can tolerate intensive therapy and those requiring supportive care.
Conclusions:
- A specialized strategy for screening, diagnosis, and therapy in elderly NSCLC patients is crucial.
- Integrating geriatric and oncologic information improves patient selection for tailored NSCLC treatments.
- This integrated approach optimizes care by matching therapy intensity to individual patient profiles, including those with non-small-cell lung cancer.